Main Menu Search
Development of molecular target-oriented recombinant antibodies as innovative therapeutics against promestatic and proangiogenic mediators of cancer microenvironment.
Back to project overview
We use cookies for statistical purposes and to remember your settings. Please check our privacy and cookies policy.